<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2026-05-11</publicationDate>
    
        <volume>23</volume>
        <issue>2</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>58891</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Development and HPTLC Standardization of an Ayurvedic Avleha-Based Nutraceutical Formulation of Manilkara zapota Fruit Extract with Simultaneous Estimation of Gallic Acid and Ellagic Acid</title>

    <authors>
	 


      <author>
       <name>Daksha Lalit Attarde</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Sarika Tanaji Nikam</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Komal Bhausaheb Dawange</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Pharmacognosy, Mahatma Gandhi Vidyamandir’s Pharmacy College, Nashik, India.</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Pharmacognosy, Dr. D.Y. Patil Institute of PharmaceuticalScience & Research, Pune, India.</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">The growing prevalence of oxidative stress-associated disorders highlights the need for standardized herbal nutraceuticals with proven antioxidant potential. The present study aimed to develop and HPTLC standardize an Ayurvedic Avleha-based nutraceutical formulation containing extract of <em>Manilkara zapota</em> fruit. The extract exhibited significant phytochemical richness, with total polyphenolic content of 290 mg/g (gallic acid equivalent), total flavonoid content of 31.06 mg/g (rutin equivalent), and total flavonol content of 2.5 mg/g (rutin equivalent). Antioxidant activity assessed by DPPH assay showed an IC₅₀ value of 5180 µg/mL for the extract, compared to 4.12 µg/mL for ascorbic acid. Among the developed batches, Batch III showed optimal physicochemical characteristics and was selected for further evaluation. HPTLC analysis using a validated method with mobile phase Toluene: Ethyl acetate: Formic acid: Methanol (6:6:1.6:0.4 v/v/v/v) at 275 nm revealed well-resolved peaks with Rf values of 0.39 and 0.29 for gallic acid and ellagic acid, respectively. Simultaneous estimation showed that gallic acid and ellagic acid contents were 0.6312% w/w and 0.6918% w/w in the extract, and 0.09421% w/w and 0.04420% w/w in the formulation, respectively. The method was validated as per ICH guidelines and found to be linear, precise, accurate, and robust, supporting its suitability for routine analysis.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol23no2/development-and-hptlc-standardization-of-an-ayurvedic-avleha-based-nutraceutical-formulation-of-manilkara-zapota-fruit-extract-with-simultaneous-estimation-of-gallic-acid-and-ellagic-acid/</fullTextUrl>



      <keywords language="eng">
        <keyword>Avleha formulation;<em> </em>Ellagic acid;<em> </em>Gallic acid;<em> </em>HPTLC; Manilkara zapota<em>;</em> Sapodilla</keyword>
      </keywords>

  </record>
</records>